ECRM Specialty Rx Panel Discussion Coverage (CDR) 3/16/2015
Specialty pharmaceuticals are the fastest-growing segment of the pharmacy business, but the sizable opportunity that they represent comes with a steep learning curve for new participants in the market.
So noted the participants in a panel discussion at ECRM's recent specialty pharmacy event in New Orleans.
The full article is available at Chain Drug Review
The ECRM panelists included Avella's Leslie Yendro, Diplomat's Cheryl Allen, Two Lab's Will Pih, and Takeda's Chris Glessinge
